DXC Commercial and Professional Services Kalamazoo, Michigan, USA

Quantum Regulatory Solutions

Document Processing · Security and Compliance

Quantum needed to prepare FDA-compliant regulatory applications faster and more reliably because filing delays, rejection, or resubmission can postpone clinical trials and keep new therapies from reaching patients on time.

accelerate regulatory filings by up to 60%
more than 10 years
reduces our processing time by 50%

Reported impact

Business outcome

Quantum says the deployment reduced document-processing time, increased its capacity to take on new business, and kept client submissions on track so new drugs can move to market faster.

  • Compliance
  • Productivity Improvement
  • Revenue Growth
  • Speed to Market

Solution

Quantum standardized regulatory publishing on DXC ToolBox Pharma Edition, a regulatory information management application that assembles FDA-compliant submission documents. Client content such as toxicology reports, manufacturing procedures, and clinical trial protocols is organized into FDA-approved templates so Quantum can produce Investigational New Drug and related regulatory packages with less manual effort. The latest deployment adds DXC FirstPoint RIM.AI, a cloud-native AI automation framework that accelerates document processing and filing workflows inside the platform. Together, the tools reduce processing time, expand capacity for new client work, and help pharmaceutical and biotech customers keep submissions on track so clinical trials and approvals are not delayed. The source does not name a separate storage layer, but it clearly positions ToolBox and RIM.AI as the governed production system for regulatory document automation.

Data flow

Pharmaceutical and biotech customer data, including toxicology, manufacturing, and clinical-trial protocol details, enters DXC ToolBox Pharma Edition and is organized into FDA-approved templates. DXC FirstPoint RIM.AI automates processing inside the workflow, after which Quantum publishes the completed IND and other regulatory submission packages for FDA review.

Solution architecture

2 components · 2 layers
  1. Compute
    • DXC FirstPoint RIM.AI Applies cloud-native AI automation to accelerate document processing and filing workflows.
  2. Orchestration
    • DXC ToolBox Pharma Edition Organizes regulatory content into FDA-compliant templates and manages document production for submissions.

Architecture clues

  • DXC FirstPoint RIM.AI is explicitly described as a cloud-native AI automation framework.
  • DXC ToolBox Pharma Edition is described as a regulatory information management application for FDA-compliant document production.
  • The workflow centers on IND and marketing-approval packages assembled from regulated source documents and templates.

Evidence from the source

"DXC ToolBox reduces our processing time by 50%."
"DXC Toolbox Pharma's latest version [v6.5] uses DXC's FirstPoint RIM.AI - a cloud-native AI Automation framework - to accelerate regulatory filings by up to 60%."
"Not only has Quantum's capacity to take on new business increased as a result, but by successfully processing clients' regulatory applications it helps these companies keep on track with regulatory requirements as they run their clinical trials and beyond."
"Quantum uses DXC's ToolBox Pharma Edition, a regulatory information management (RIM) application that streamlines production of FDA-compliant documents."
"Ultimately, this helps Quantum's pharmaceutical customers accelerate the journey of new drugs to market."
Transparency Evidence & methodology 100/100 reference value · 95% confidence · 2 sources

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value100/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    2 metrics describe measurable impact.
  • Deployment scale10/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence95%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability25/25
    12 of 12 key fields link to a named source.
  • Direct evidence20/20
    5 direct source quotes retained.
  • Date provenance10/10
    The publication date comes from the source page or publisher.
  • Source transparency10/10
    2 source references document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. DXC Technology

    Pharmaceutical Compliance Software Integration for Quantum | DXC Customer Stories

    First-party
    https://dxc.com/insights/customer-stories/quantum-dxc-pharmaceutical-regulatory-compliance-software-integration
    Source type
    Vendor-published customer story
    Published
    Jun 3, 2025
    Supports
    • Customer
    • Industry
    • Region
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • Business outcome
    • Metrics
    • Architecture
    • Publication date
    • evidence quotes
  2. LinkedIn

    Quantum Regulatory Solutions, LLC | LinkedIn

    Independent secondary
    https://www.linkedin.com/company/quantum-regulatory-solutions/

    The page JSON-LD lists numberOfEmployees value 26 for Quantum Regulatory Solutions, LLC; the standard mapping classifies fewer than 250 employees as SMB.

    Source type
    Structured company profile
    Supports
    • Company size

Date evidence